126 related articles for article (PubMed ID: 38493947)
1. Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer.
Wu J; Gao F; Meng R; Li H; Mao Z; Xiao Y; Pu Q; Du M; Zhang Z; Shao Q; Zheng R; Wang M
Toxicology; 2024 May; 504():153782. PubMed ID: 38493947
[TBL] [Abstract][Full Text] [Related]
2. Revolutionary multi-omics analysis revealing prognostic signature of thyroid cancer and subsequent in vitro validation of SNAI1 in mediating thyroid cancer progression through EMT.
Jin X; Fu C; Qi J; Chen C
Clin Exp Med; 2024 Jun; 24(1):127. PubMed ID: 38869635
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
Liu B; Pan S; Liu J; Kong C
Gene; 2021 Apr; 775():145451. PubMed ID: 33482279
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
5. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
6. A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer.
Hou J; Wen X; Lu Z; Wu G; Yang G; Tang C; Qu G; Xu Y
Front Immunol; 2022; 13():970949. PubMed ID: 36211359
[TBL] [Abstract][Full Text] [Related]
7. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
8. AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.
Xiao Y; Shen Y; Song H; Gao F; Mao Z; Lv Q; Qin C; Yuan L; Wu D; Chu H; Wang M; Du M; Zheng R; Zhang Z
Arch Toxicol; 2024 Jul; 98(7):2269-2279. PubMed ID: 38662237
[TBL] [Abstract][Full Text] [Related]
9. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
10. Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.
Zhang Z; Liang Z; Li D; Wang L; Chen Y; Liang Y; Jiao W; Niu H
Hum Cell; 2022 Mar; 35(2):649-664. PubMed ID: 35044630
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoke extract induces epithelial-mesenchymal transition of human bladder cancer T24 cells through activation of ERK1/2 pathway.
Sun X; Deng Q; Liang Z; Liu Z; Geng H; Zhao L; Zhou Q; Liu J; Ma J; Wang D; Yu D; Zhong C
Biomed Pharmacother; 2017 Feb; 86():457-465. PubMed ID: 28012925
[TBL] [Abstract][Full Text] [Related]
14. Identification of an immune gene-associated prognostic signature in patients with bladder cancer.
Wang Z; Zhu L; Li L; Stebbing J; Wang Z; Peng L
Cancer Gene Ther; 2022 May; 29(5):494-504. PubMed ID: 35169299
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
16. Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients.
Fantini D; Seiler R; Meeks JJ
Urol Oncol; 2019 Nov; 37(11):818-825. PubMed ID: 30446446
[TBL] [Abstract][Full Text] [Related]
17. Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer.
Lyu X; Wang P; Qiao Q; Jiang Y
BMC Cancer; 2021 May; 21(1):646. PubMed ID: 34059019
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy.
Su Z; You L; He Y; Chen J; Zhang G; Liu Z
Sci Rep; 2024 Jan; 14(1):2189. PubMed ID: 38273010
[TBL] [Abstract][Full Text] [Related]
19. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
20. Weighted gene co-expression network analysis can sort cancer-associated fibroblast-specific markers promoting bladder cancer progression.
Liu B; Zhan Y; Chen X; Hu X; Wu B; Pan S
J Cell Physiol; 2021 Feb; 236(2):1321-1331. PubMed ID: 32657439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
